(Q80104291)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16906786%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

title

Efavirenz/emtricitabine/tenofovir disoproxil fumarate: triple combination tablet (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16906786%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

1 reference

1 reference

James E Frampton

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16906786%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Katherine F Croom

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16906786%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

publication date

1 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16906786%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16906786%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

66

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16906786%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16906786%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

1501-12; discussion 1513-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16906786%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00003495-200666110-00012

28 December 2019

exact match

0 references

cites work

Clinical pharmacokinetics of non-nucleoside reverse transcriptase inhibitors

1 reference

12 December 2020

Emtricitabine/tenofovir disoproxil fumarate

1 reference

12 December 2020

Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection

1 reference

12 December 2020

Efavirenz: a pharmacoeconomic review of its use in HIV infection

1 reference

12 December 2020

Efavirenz: enhancing the gold standard.

1 reference

12 December 2020

Pharmacologic perspectives for once-daily antiretroviral therapy

1 reference

12 December 2020

Primary care guidelines for the management of persons infected with human immunodeficiency virus: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America

1 reference

12 December 2020

Tenofovir disoproxil fumarate: a review of its use in the management of HIV infection

1 reference

12 December 2020

Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.

1 reference

12 December 2020

Emtricitabine: a review of its use in the management of HIV infection

1 reference

12 December 2020

1 reference

12 December 2020

Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV.

1 reference

12 December 2020

Update on HIV infection.

1 reference

12 December 2020

Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing non-nucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: open-label randomised trial.

1 reference

12 December 2020